Pituitary Adenoma
71
13
18
29
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
4.2%
3 terminated out of 71 trials
90.6%
+4.1% vs benchmark
10%
7 trials in Phase 3/4
7%
2 of 29 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 29 completed trials
Clinical Trials (71)
AI in Endoscopic Transsphenoidal Surgery
A First in Human Study Using 89Zr-cRGDY Ultrasmall Silica Particle Tracers for Malignant Brain Tumors
Defining the Genetic Basis for the Development of Primary Pigmented Nodular Adrenocortical Disease (PPNAD) and the Carney Complex
Effect of Foot Bath on Anxiety and Physiological Parameters
DDAVP for Pituitary Adenoma
Hypofractionated Radiosurgery to Treat Residual/Recurrent Non Secreting Pituitary Adenoma (HYPOADENO)
Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures
OCT-angiography as a Pronostic Marker for Visual Impairment in Patients Undergoing Neurosurgery for Compressive Macroadenoma : a Prospective Study.
FET PET/CT Imaging To Localize Pituitary Adenomas In Cushing Disease
Use of [18F] Fluoroethyl-L-tyrosine PET/MRI for Identifying Small Functional Pituitary Adenomas
Prediction Model for Postoperative Headache After Transsphenoidal Pituitary Surgery
Evaluation of Intraoperative Contrast Enhanced Ultrasound for the Identification of Pituitary Adenoma in Cushing's Disease Compared to Other Pituitary Tumors
Molecular Pituitary Imaging Using 18F-FET PET
Clinical Trial of an Anti-Fog Drainage Device for Endoscopic Endonasal Sellar Region Tumor Surgery
68-Ga DOTATATE PET/MRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors.
Proton Versus Photon Radiotherapy in Adults With Primary Brain Tumors
Cabergoline in the Management of Nonfunctioning Pituitary Adenoma
DOTATOC PET/CT for Imaging NET Patients
Comparison of Postoperative Recovery of Sevoflurane and Propofol After Transsphenoidal Surgery
A Twenty-years' Experience in Pituitary Disease.